Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications
Biosensors and Bioelectronics · 2023
DOI: 10.1016/j.bios.2023.115589 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biosensors and Bioelectronics, 2023. Verfasst von Yi Li und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Hauptthemen laut MEDLINE: Biosensing Techniques, DNA, Catalytic. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Natural Science Foundation of Chongqing Municipality, Chongqing Medical University.
Abstract (Originalsprache)
Given the targeted binding ability and cleavage activity of the emerging CRISPR/Cas12a assay which transduces the target into its cleavage activity exhibited broadly prospective applications in integrated sensing and actuating system. Here, we elaborated a universal approach to quickly activate CRISPR/Cas12a for low-abundance biomarker detection based on the amplification strategy of a target-induced spherical nucleic acid enzyme (SNAzyme) network that could accelerate the output of activators. Specifically, multifunctional Y-shaped probes and hairpin probes (HPs, which contained the specific sequence of the activators of CRISPR/Cas12a and the substrate chain of DNAzyme) were rationally designed to construct SNAzyme. Target recognition induced disassembly of the Y-shaped probes, which released DNAzyme strands to active DNAzyme and accompanied by SNAzyme self-assembly into SNAzyme network. Interestingly, compared with randomly dispersed SNAzyme, the reaction kinetics of the SNAzyme network enhanced 1.6 times in response to Α-methyl acyl-CoA racemase (AMACR, a biomarker for prostate cancer), which was attributed to the promoted catalytic efficiency of DNAzyme by the confined SNAzyme network. Benefiting from these, the prepared biosensor based on electrochemiluminescence (ECL) platform by loading AuAg nanoclusters (AuAgNCs) into metal-organic framework-5 (MOF-5) exhibited satisfying detection performance for AMACR with a wide linear range (0.001 μg/mL to 100 μg/mL) and a low detection limit (1.0 × 10-4 μg/mL, which exhibited significant potential in clinical diagnoses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
- Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University), Ministry of Education, College of Chemistry and Chemical Engineering, Southwest University, Chongqing, China.
- Department of Radiology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Electronic address: he_xiaojing@hospital.cqmu.edu.cn.
Förderung
- Natural Science Foundation of Chongqing Municipality
- Chongqing Medical University
Zitieren
APA
Li, Y., Liu, M. L., Liang, W. B., Zhuo, Y., & He, X. J. (2023). Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications. Biosensors and Bioelectronics. https://doi.org/10.1016/j.bios.2023.115589
Vancouver
Li Y, Liu ML, Liang WB, Zhuo Y, He XJ. Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications. Biosensors and Bioelectronics. 2023. doi:10.1016/j.bios.2023.115589
BibTeX
@article{Li2023,
author = {Li, Yi and Liu, Mei-Ling and Liang, Wen-Bin and Zhuo, Ying and He, Xiao-Jing},
title = {Spherical nucleic acid enzyme programmed network to accelerate CRISPR assays for electrochemiluminescence biosensing applications},
journal = {Biosensors and Bioelectronics},
year = {2023},
doi = {10.1016/j.bios.2023.115589}
}
EUVIMED